Equillium stock falls after announcing cryptocurrency treasury strategy

Published 04/08/2025, 14:26
© Reuters.

Investing.com -- Equillium Inc (NASDAQ:EQ) stock tumbled 12.4% after the biotechnology company announced plans to integrate cryptocurrency into its treasury reserve strategy, a significant deviation from its core business of developing treatments for autoimmune and inflammatory disorders.

The San Diego-based company revealed it would begin holding digital currencies as part of its financial and growth objectives while continuing to pursue its biotech mission. CEO Bruce Steel stated the move was made for "diversification, liquidity and long-term capital appreciation potential," with additional updates on the strategy expected during the third quarter of 2025.

Investors appeared concerned about the shift in focus, particularly given the company’s limited cash reserves. Equillium disclosed approximately $11.5 million in cash and cash equivalents as of June 30, 2025, which it projects will fund operations only into the fourth quarter of 2025.

Despite the cryptocurrency initiative, Equillium maintains it will continue advancing its therapeutic pipeline, including preparing EQ504, its novel aryl hydrocarbon receptor modulator, for clinical development. The company noted it has implemented operating changes to decrease expenditures and conserve cash.

The stock’s sharp decline reflects investor skepticism about the biotech firm’s unexpected venture into cryptocurrency, which represents a departure from its established focus on developing novel therapies for severe medical conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.